Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2005;331 (16 July), doi:10.1136/bmj.331.7509.0-e
In a clinical review on page 155, Moncrieff and Kirsch take a close look at available evidence for and against the use of selective serotonin reuptake inhibitors (SSRIs) in treating depression. Current approaches to depression should be re-evaluated, they say, and alternatives to drug treatment should be developed further. Since antidepressants have become society's main response to distress, the authors say that expectations raised by decades of use will also need to be addressed.
|
|
Credit: CRISTINA PEDRAZZINI/SPL
|
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Read all Rapid Responses